112 related articles for article (PubMed ID: 11789558)
1. Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Endocr J; 2001 Oct; 48(5):543-9. PubMed ID: 11789558
[TBL] [Abstract][Full Text] [Related]
2. Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Urol Int; 2002; 68(4):226-31. PubMed ID: 12053022
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor gene polymorphism and prostate cancer risk.
Gsur A; Madersbacher S; Haidinger G; Schatzl G; Marberger M; Vutuc C; Micksche M
Prostate; 2002 Apr; 51(1):30-4. PubMed ID: 11920955
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor polymorphisms and lethal prostate cancer.
Kibel AS; Isaacs SD; Isaacs WB; Bova GS
J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor polymorphisms and prostate cancer.
Blazer DG; Umbach DM; Bostick RM; Taylor JA
Mol Carcinog; 2000 Jan; 27(1):18-23. PubMed ID: 10642433
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor gene polymorphism in Japanese patients with prostate cancer.
Furuya Y; Akakura K; Masai M; Ito H
Endocr J; 1999 Jun; 46(3):467-70. PubMed ID: 10504001
[TBL] [Abstract][Full Text] [Related]
7. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.
Watanabe M; Fukutome K; Murata M; Uemura H; Kubota Y; Kawamura J; Yatani R
Anticancer Res; 1999; 19(5C):4511-4. PubMed ID: 10650802
[TBL] [Abstract][Full Text] [Related]
8. Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese.
Ikuyama T; Hamasaki T; Inatomi H; Katoh T; Muratani T; Matsumoto T
Endocr J; 2002 Aug; 49(4):433-8. PubMed ID: 12402975
[TBL] [Abstract][Full Text] [Related]
9. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
10. Association of a vitamin D receptor gene polymorphism with localized early-onset periodontal diseases.
Hennig BJ; Parkhill JM; Chapple IL; Heasman PA; Taylor JJ
J Periodontol; 1999 Sep; 70(9):1032-8. PubMed ID: 10505806
[TBL] [Abstract][Full Text] [Related]
11. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor.
Jackman SV; Kibel AS; Ovuworie CA; Moore RG; Kavoussi LR; Jarrett TW
J Endourol; 1999 May; 13(4):313-6. PubMed ID: 10405913
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population.
Suzuki K; Matsui H; Ohtake N; Nakata S; Takei T; Koike H; Nakazato H; Okugi H; Hasumi M; Fukabori Y; Kurokawa K; Yamanaka H
Int J Urol; 2003 May; 10(5):261-6. PubMed ID: 12694466
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
14. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.
Chen L; Davey Smith G; Evans DM; Cox A; Lawlor DA; Donovan J; Yuan W; Day IN; Martin RM; Lane A; Rodriguez S; Davis M; Zuccolo L; Collin SM; Hamdy F; Neal D; Lewis SJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2874-81. PubMed ID: 19861519
[TBL] [Abstract][Full Text] [Related]
16. [Association of vitamin D receptor gene polymorphism with prostate cancer].
Hamasaki T; Inatomi H; Matsumoto T; Katoh T
Nihon Rinsho; 2002 Dec; 60 Suppl 11():465-8. PubMed ID: 12599620
[No Abstract] [Full Text] [Related]
17. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
[TBL] [Abstract][Full Text] [Related]
18. Association between vitamin D receptor ApaI and TaqI gene polymorphisms and gestational diabetes mellitus in an Iranian pregnant women population.
Rahmannezhad G; Mashayekhi FJ; Goodarzi MT; Rezvanfar MR; Sadeghi A
Gene; 2016 Apr; 581(1):43-7. PubMed ID: 26784653
[TBL] [Abstract][Full Text] [Related]
19. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
Andersson P; Varenhorst E; Söderkvist P
Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
